These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38128117)

  • 1. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
    Yuk JS; Park JY
    PLoS One; 2023; 18(12):e0294356. PubMed ID: 38048308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
    Yuk JS; Kim JM
    Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study.
    Yuk JS; Lee JS; Park JH
    Front Aging Neurosci; 2023; 15():1213481. PubMed ID: 37744387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2024 Aug; 166(2):735-744. PubMed ID: 38469634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim M
    Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea.
    Yuk JS; Kim BY
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study.
    Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG
    BJOG; 2024 Aug; 131(9):1306-1317. PubMed ID: 38465460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea.
    Yuk JS; Park JY; Sim HE; Hwang JH
    Ophthalmic Physiol Opt; 2023 Mar; 43(2):254-262. PubMed ID: 36609995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
    Yuk JS; Jeong SH
    J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
    Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
    Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
    Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
    J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
    Chlebowski RT; Aragaki AK
    Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal Hormone Therapy and Osteoarthritis Risk: Retrospective Population-Based Study in South Korea.
    Lee JL; Seo J; Shin Y; Han GH; Yoon SH; Noh JH; Kim MH; Yuk JS
    J Menopausal Med; 2024 Aug; 30(2):78-87. PubMed ID: 39315500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.